Stock BJ9 BENITEC BIOPHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Benitec Biopharma Inc. Deutsche Boerse AG

Equities

BJ9

US08205P2092

Delayed Deutsche Boerse AG
Other stock markets
 07:11:42 25/07/2023 BST 		5-day change 1st Jan Change
3.06 EUR -2.70% Intraday chart for Benitec Biopharma Inc. -.--% -.--%
05-13 Benitec Biopharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
04-22 Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors CI

Evolution of the average Target Price on Benitec Biopharma Inc.

Price target over the last 5 years

History of analyst recommendation changes

194.YnByPsENDrxxmtMcjCN-fEEM9Eiob9roJ4DbMosWMjA.A0gFU4pPX_UW9phqxlcKDih4lhrRHYDFfteaBfJCW3k7KSgL-Vg9xEPqtA~a370fe81067019ab6a8a04b42453fbb7

Analyst Recommendations on Benitec Biopharma Inc.

JMP Securities Adjusts Benitec Biopharma's Price Target to $8 From $6, Keeps Market Outperform Rating MT
JMP Securities Starts Benitec Biopharma at Market Outperform With $4 Price Target MT
HC Wainwright Adjusts Price Target on Benitec Biopharma to $4 From $10, Reiterates Buy Rating MT
HC Wainwright Initiates Benitec Biopharma at Buy With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
11.52 AUD
Average target price
23.94 AUD
Spread / Average Target
+107.75%
High Price Target
23.94 AUD
Spread / Highest target
+107.75%
Low Price Target
23.94 AUD
Spread / Lowest Target
+107.75%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Benitec Biopharma Inc.

JMP Securities
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BNTC Stock
  4. BJ9 Stock
  5. Consensus Benitec Biopharma Inc.